Abstract |
We describe a boy with Fisher syndrome. He presented the typical symptoms of Fisher syndrome, including external ophthalmoplegia, abnormality of convergence, and areflexia, after an episode of Campylobacter enterocolitis. Atypically, however, anti-GA1 antibody was detected in his serum, though anti-GQ1b and anti-GT1a antibodies were not. In addition, the tau protein level in his cerebrospinal fluid was elevated. Generally, Fisher syndrome is a self-limiting disease and has a good prognosis. In our patient, however, mild diplopia and areflexia persisted 6 months after their onset. Here, we report on the first Fisher syndrome patient with anti-GA1 antibody in the serum and elevated tau protein in the cerebrospinal fluid.
|
Authors | Yoshinobu Oyazato, Takashi Shiihara, Susumu Kusunoki, Masao Adachi, Noriko Ohnishi, Hiroaki Taniguchi, Atsushi Nishiyama, Aika Watanabe, Mitsuro Kobayashi, Ichiro Kamioka |
Journal | Brain & development
(Brain Dev)
Vol. 34
Issue 4
Pg. 329-32
(Apr 2012)
ISSN: 1872-7131 [Electronic] Netherlands |
PMID | 21742448
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Autoantibodies
- G(A1) ganglioside
- Gangliosides
- tau Proteins
|
Topics |
- Autoantibodies
(biosynthesis, blood)
- Autoimmune Diseases of the Nervous System
(cerebrospinal fluid, immunology, microbiology)
- Campylobacter Infections
(cerebrospinal fluid, immunology)
- Child
- Gangliosides
(immunology)
- Humans
- Male
- Miller Fisher Syndrome
(cerebrospinal fluid, immunology, microbiology)
- Up-Regulation
(immunology)
- tau Proteins
(biosynthesis, blood, cerebrospinal fluid)
|